Arthur Tzianabos

Insider profile

Currently holds positions in Akouos Inc, Stoke Therapeutics Inc and Q32 Bio Inc

Positions

Position Company Period
Director Akouos Inc None -
Independent Director Stoke Therapeutics Inc Sept. 1, 2018 -
President, Chief Executive Officer, Director Q32 Bio Inc Jan. 1, 2016 -
President, Chief Scientific Officer Millendo Therapeutics Inc Dec. 9, 2014 - March 31, 2016
President, Chief Executive Officer Q32 Bio Inc None -
Chief Scientific Officer Millendo Therapeutics Inc July 30, 2013 - Dec. 9, 2014

Arthur Tzianabos's trades of Stoke Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
209.17
Quantity 90,530 -8.2%
Value US$3,221,512
Transaction date
Sale
Price
324.78
Quantity 2,864 +48.7%
Value US$1,952,934
Transaction date
Planned sale
Price
0.57
Quantity 13,037 -9.2%
Value US$7,445
Transaction date
Planned sale
Price
1.39
Quantity 10,616 -8.9%
Value US$14,762
Transaction date
Planned sale
Price
3.78
Quantity 5,354 -5.9%
Value US$20,239
Transaction date
Planned sale
Price
16.16
Quantity 12,500 -13.9%
Value US$202,021
Transaction date
Planned sale
Price
20.50
Quantity 12,500 -12.2%
Value US$256,191
Transaction date
Planned sale
Price
18.23
Quantity 100 -0.1%
Value US$1,823
Transaction date
Planned sale
Price
17.39
Quantity 12,400 -8.9%
Value US$215,645
Transaction date
Planned sale
Price
18.75
Quantity 12,500 -8.2%
Value US$234,320
Transaction date
Planned sale
Price
18.98
Quantity 12,500 -7.0%
Value US$237,300
Transaction date
Planned sale
Price
19.86
Quantity 12,500 -6.6%
Value US$248,262
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-03-12 2026-03-10 PlS Planned sale
90,530 -8.2%
209.17
US$3,221,512
90,530 -8.2% 209.17 US$3,221,512
2026-03-10 2026-03-10 PrS Proposed sale
36,695
433.14
US$3,069,295
36,695 433.14 US$3,069,295
2024-08-14 2024-03-25 S Sale
2,864 +48.7%
324.78
US$1,952,934
2,864 +48.7% 324.78 US$1,952,934
2024-02-15 2024-01-09 PlS Planned sale
13,037 -9.2%
0.57
US$7,445
13,037 -9.2% 0.57 US$7,445
2023-01-11 2023-01-09 PlS Planned sale
10,616 -8.9%
1.39
US$14,762
10,616 -8.9% 1.39 US$14,762
2022-01-12 2022-01-05 PlS Planned sale
5,354 -5.9%
3.78
US$20,239
5,354 -5.9% 3.78 US$20,239
2021-02-23 2021-02-19 PlS Planned sale
10,000 -100.0%
60.67
US$606,652
10,000 -100.0% 60.67 US$606,652
2020-11-25 2020-11-23 PlS Planned sale
210 -100.0%
47.61
US$9,998
210 -100.0% 47.61 US$9,998
2020-11-25 2020-11-23 PlS Planned sale
5,294 -96.2%
46.85
US$248,009
5,294 -96.2% 46.85 US$248,009
2020-11-25 2020-11-23 PlS Planned sale
10,196 -64.9%
45.97
US$468,720
10,196 -64.9% 45.97 US$468,720
2020-11-25 2020-11-23 PlS Planned sale
4,300 -21.5%
45.08
US$193,838
4,300 -21.5% 45.08 US$193,838
2020-02-05 2020-02-03 PlS Planned sale
12,500 -13.9%
16.16
US$202,021
12,500 -13.9% 16.16 US$202,021
2020-01-03 2020-01-02 PlS Planned sale
12,500 -12.2%
20.50
US$256,191
12,500 -12.2% 20.50 US$256,191
2019-10-02 2019-10-01 PlS Planned sale
100 -0.1%
18.23
US$1,823
100 -0.1% 18.23 US$1,823
2019-10-02 2019-10-01 PlS Planned sale
12,400 -8.9%
17.39
US$215,645
12,400 -8.9% 17.39 US$215,645
2019-09-05 2019-09-03 PlS Planned sale
12,500 -8.2%
18.75
US$234,320
12,500 -8.2% 18.75 US$234,320
2019-07-03 2019-07-01 PlS Planned sale
12,500 -7.0%
18.98
US$237,300
12,500 -7.0% 18.98 US$237,300
2019-06-05 2019-06-03 PlS Planned sale
12,500 -6.6%
19.86
US$248,262
12,500 -6.6% 19.86 US$248,262